PDS Biotechnology Corporation Common Stock — Institutional Ownership
Which tracked institutions hold PDSB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
13
Funds holding
$1256780
Total value held
Buying
9 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $535391 | 607639 | +53591 | +9.67% |
| 2 | Morgan Stanley | $276597 | 313922 | +310000 | +7904.13% |
| 3 | State Street Corp | $117480 | 133333 | — | Held |
| 4 | Northern Trust Corp | $111461 | 126502 | +17609 | +16.17% |
| 5 | Wells Fargo & Company/Mn | $96040 | 109000 | -1500 | -1.36% |
| 6 | Bank Of New York Mellon Corp | $60348 | 68491 | -820 | -1.18% |
| 7 | Raymond James Financial Inc | $29798 | 33819 | +23583 | +230.39% |
| 8 | Pnc Financial Services Group, Inc. | $10484 | 11900 | +11900 | NEW BUY |
| 9 | Ubs Group Ag | $9798 | 11121 | +11121 | NEW BUY |
| 10 | Goldman Sachs Group Inc | $8853 | 10048 | +10048 | NEW BUY |
| 11 | Barclays Plc | $513 | 582 | +582 | NEW BUY |
| 12 | Jpmorgan Chase & Co | $17 | 19 | — | Held |
| 13 | Royal Bank Of Canada | $0 | 80 | +5 | +6.67% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.